Pharmaguy's Insights Into Drug Industry News
186.0K views | +30 today
Follow
Pharmaguy's Insights Into Drug Industry News
Pharmaguy curates and provides insights into selected drug industry news and issues.
Curated by Pharma Guy
Your new post is loading...
Your new post is loading...
Scooped by Pharma Guy
Scoop.it!

PinUp: FDA Muzzles Journalists, Cancer Drug.com Sites Emphasize Positive, Prescribing Medical Mobile Apps, More...

PinUp: FDA Muzzles Journalists, Cancer Drug.com Sites Emphasize Positive, Prescribing Medical Mobile Apps, More... | Pharmaguy's Insights Into Drug Industry News | Scoop.it

Welcome to the September 27, 2016, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.

 

---------------

Featured Event

West Coast Electronic Benefit Verification & Prior Authorization Summit

25 - 26 October 2016 | San Francisco, CA

http://bit.ly/MTG1355fl

 

---------------

How the FDA Turns Journalist Watchdogs Into Lapdogs

  

Documents obtained by Scientific American through Freedom of Information Act requests now paint a disturbing picture of the tactics that are used to control the science press. For example, the FDA assures the public that it is committed to transparency, but the documents show that, privately, the agency denies many reporters access - including ones from major outlets such as Fox News - and even deceives them with half-truths to handicap them in their pursuit of a story. 

 

More here... http://sco.lt/9AcuG1 

 

FDA isn't alone in manipulating the press. Read, for example, "Academics Exaggerate, Journalists Regurgitate"; http://sco.lt/8sNzPN  and "Bad Journalism Abets Bad Pharma: Philly Inquirer Editors Raked Over Coals"; http://sco.lt/7rkRZB 

 

---------------

Just Like DTC Ads, Pharma Cancer Drug Websites Emphasize Benefits Over Risks

 

Researchers from the US Food and Drug Administration's (FDA) Office of Prescription Drug Promotion (OPDP) and research firm RTI International say that websites for cancer-drugs are ten times more likely to include quantitative information about all the benefits of a drug versus all its risks.

 

More here... http://sco.lt/8soJrV 

 

Also read: "Oncologists Say Cancer Drug Advertising Fosters Misinterpretation of Efficacy by Patients"; http://sco.lt/8Imgdd  and " Breakthrough Cancer Therapy DTC Advertising Boldly Emphasizes the Positive"; http://sco.lt/80LqSX 

 

---------------

Apple Hires YouTube @DocMikeEvans to Prescribe Health Apps!

 

Mike Evans, known on YouTube as "DocMikeEvans," has joined Apple to work on digital health care. Evans is best known for his videos where he narrates while an animated doctor gives health tips and advice.

 

"In future, I'll prescribe you an app. One of our whiteboards will drop in and explain what high blood pressure is. The phone will be Bluetoothed to the cap of your pills. I'll nudge you towards a low salt diet. All of these things will all happen in your phone. I see you two or three days a year. The phone sees you everyday."

 

 

More here... http://sco.lt/5urPMX 

 

You might also be interested in reading: "AMA CEO Calls Out Medical Apps as 'Digital Snake Oil'"; http://sco.lt/8zuIld  and "Most Doctors Not Yet Ready to Recommend Mobile Apps & Wearable to Patients"; http://sco.lt/8yujoX  and " Kevin Pho, MD, is not ready to prescribe mobile health apps. Why not?"; http://sco.lt/8oj9rV 

 

---------------

Forget Mobile-Enabled Web - You Need an App for That + Video!

 

This year, US adults will spend 1 hour and 54 minutes a day using apps on their smartphones, 7 minutes more than last year. In contrast, they’ll only surf the mobile web on their phones for 19 minutes a day, a decline of 2 minutes from last year. In other words, apps will account for 86% of adults' nonvoice smartphone time this year, with the mobile web accounting for just 14%.

 

More here... http://sco.lt/7QzAbR 

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

What's pharma's impact on the mobile health app space? These 3 graphs offer some clues

What's pharma's impact on the mobile health app space? These 3 graphs offer some clues | Pharmaguy's Insights Into Drug Industry News | Scoop.it
A report highlighting the mobile health app landscape charts pharma companies that have produced the most apps, such as Bayer, Merck and Novartis.


Bayer, Merck and Novartis top the list. Many of them are designed as companion apps for drugs and devices. An app that is available in several languages could also account for some of the relatively high numbers. Some areas of app development Bayer has covered include helping multiple sclerosis patients manage their meds. recording hemophilia A factor VIII infusions and monitoring diet, particularly for people with diabetes. Among the apps Novartis produced include tools for managing cystic fibrosis. Novartis’ oncology division produced a few apps too, such as My Acro Manager to help patients with Acromegaly track test results, medication updates and improve their knowledge of their condition. Medication adherence apps and a tool to track symptoms from HIV treatment are among Merck’s apps

Pharma Guy's insight:


Obviously, this is NOT a numbers game! It's all about utility, quality, and usability, which many pharma mobile apps lack. Read "The Sorry State of Pharma Mobile Apps"


At a recent eyeforpharma Philadelphia 2014 Summit, Carolyn Gauntlett, Senior Innovation Consultant with IMS Health, gave an interesting presentation titled "How to Make Sure You're Getting the Most Out of Your mHealth App Development."

This article summarizes some major points made in that presentation as well as data from the report "Patient Apps for Improved Healthcare: From Novelty to Mainstream" published by IMS Institute for Healthcare Informatics. 

Topics include (partial list):

  • Some Docs Prescribe More Apps Than Pills
  • So, Why Hasn't Mobile Health "Exploded?"
  • More Apps, Less Meds?
  • Few mHealth Apps Are Worthy
  • Figure: Health App Functionality Score Distribution
  • The Pharma App Black Hole
  • Poor ROI
more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

FDA Regulators Can't Scale To Police Mobile Health Apps

FDA Regulators Can't Scale To Police Mobile Health Apps | Pharmaguy's Insights Into Drug Industry News | Scoop.it
A senior advisor to the FDA said the agency couldn't possibly scale up to meet the challenge of policing the hundreds of new apps appearing every month.


The sheer pace of innovation in the mobile health application space and the numbers of such applications already available on mobile marketplaces like the iTunes App Store and Google Play mean that many mobile health applications will escape scrutiny by federal regulators, said Bakul Patel, a Policy Advisor in the FDA’s Center for Devices and Radiological Health.

Pharma Guy's insight:


Will It Be FDA Regulation or Self-Regulation or Both?


In the early days of the Internet hundreds of health Web sites of questionable quality proliferated without any guarantee of accuracy, lack of bias, privacy, etc. Today, thousands of mobile health apps of unknown quality are available for downloading by healthcare professionals and consumers.

As with Web sites in the early days, it is difficult today for users of mobile health apps to be assured that the apps are reliable, accurate, based on valid information, and adequately safeguard users' information. In many ways, we are living through another digital "wild west" without any sheriffs to protect us.

And it appears that we do need protection. 

Topics include:

  • Inaccurate Health Apps
  • Overzealous FDA Regulation?
  • The Regulation of Pharma Health Apps Survey Results
  • Good App Privacy Practices
  • Test and Document
  • Possibly the First Ever "Dear Doctor' Letter Regarding a Recall Mobile Medical App
  • Certification of Mobile Health Apps
  • Will Regulation Kill Innovation?
  • Self-Regulation: Devil's in the Details


Read this article now. It's FREE...

Download PDF file


more...
No comment yet.